HELPING TO CLEAR THE PATH TO TREATMENT
DEAD

Serial Number

86786801

Owner

OTSUKA AMERICA PHARMACEUTICAL, INC.

Attorney

B. Brett Heavner

Filing Date

Oct 13, 2015

Add to watchlist:

No watchlists yet
View on USPTO

HELPING TO CLEAR THE PATH TO TREATMENT Trademark

Serial Number: 86786801

HELPING TO CLEAR THE PATH TO TREATMENT is a trademark filed by OTSUKA AMERICA PHARMACEUTICAL, INC. on October 13, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

OTSUKA AMERICA PHARMACEUTICAL, INC. (74 trademarks)

Entity Type: 03

Trademark Details

Filing Date

October 13, 2015

Registration Date

Not Registered

Published for Opposition

July 12, 2016

Goods & Services

Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Electronic materials, namely, downloadable brochures, pamphlets, and videos about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders

Raising awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients and healthcare professionals related to health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment

Providing patient support in the nature of medical information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; discharge planning support, namely, providing medical advice to patients and healthcare providers regarding future treatment scheduling; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 8, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 8, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 8, 2018 EXRA
SOU EXTENSION 4 GRANTED
Sep 6, 2018 EX4G
SOU EXTENSION 4 FILED
Sep 6, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 6, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2018 EXRA
SOU EXTENSION 3 GRANTED
Mar 6, 2018 EX3G
SOU EXTENSION 3 FILED
Mar 6, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 6, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2017 EXRA
SOU EXTENSION 2 GRANTED
Sep 5, 2017 EX2G
SOU EXTENSION 2 FILED
Sep 5, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2017 EXRA
SOU EXTENSION 1 GRANTED
Mar 2, 2017 EX1G
SOU EXTENSION 1 FILED
Mar 2, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 2, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 8, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
May 18, 2016 XAEC
ASSIGNED TO LIE
May 18, 2016 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 18, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
May 18, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 18, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 2, 2015 GNRN
NON-FINAL ACTION E-MAILED
Nov 2, 2015 GNRT
NON-FINAL ACTION WRITTEN
Nov 2, 2015 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2015 NWOS
NEW APPLICATION ENTERED
Oct 16, 2015 NWAP